PT99661B - Processo para a preparacao de esteroides 2beta,19-etilenicos ligados em ponte - Google Patents

Processo para a preparacao de esteroides 2beta,19-etilenicos ligados em ponte Download PDF

Info

Publication number
PT99661B
PT99661B PT99661A PT9966191A PT99661B PT 99661 B PT99661 B PT 99661B PT 99661 A PT99661 A PT 99661A PT 9966191 A PT9966191 A PT 9966191A PT 99661 B PT99661 B PT 99661B
Authority
PT
Portugal
Prior art keywords
compound
group
compounds
ethylene
reaction
Prior art date
Application number
PT99661A
Other languages
English (en)
Portuguese (pt)
Other versions
PT99661A (pt
Inventor
Norton Paul Peet
John O'neal Johnston
Joseph Paul Burkhart
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PT99661A publication Critical patent/PT99661A/pt
Publication of PT99661B publication Critical patent/PT99661B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT99661A 1990-11-30 1991-11-29 Processo para a preparacao de esteroides 2beta,19-etilenicos ligados em ponte PT99661B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/621,184 US5166201A (en) 1990-11-30 1990-11-30 2β,19-ethylene bridged steroids as aromatase inhibitors

Publications (2)

Publication Number Publication Date
PT99661A PT99661A (pt) 1992-10-30
PT99661B true PT99661B (pt) 1999-05-31

Family

ID=24489093

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99661A PT99661B (pt) 1990-11-30 1991-11-29 Processo para a preparacao de esteroides 2beta,19-etilenicos ligados em ponte

Country Status (20)

Country Link
US (1) US5166201A (zh)
EP (1) EP0488383B1 (zh)
JP (1) JP3143876B2 (zh)
KR (1) KR100190776B1 (zh)
CN (1) CN1033975C (zh)
AT (1) ATE142639T1 (zh)
AU (1) AU635444B2 (zh)
CA (1) CA2056638C (zh)
DE (1) DE69122048T2 (zh)
DK (1) DK0488383T3 (zh)
ES (1) ES2094183T3 (zh)
FI (1) FI102073B1 (zh)
GR (1) GR3021981T3 (zh)
HU (1) HU210830B (zh)
IE (1) IE914168A1 (zh)
IL (1) IL100196A (zh)
NO (1) NO180304C (zh)
NZ (1) NZ240738A (zh)
PT (1) PT99661B (zh)
ZA (1) ZA919296B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510862A1 (de) * 1995-03-16 1996-09-19 Schering Ag Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3627756A (en) * 1970-04-23 1971-12-14 Searle & Co N-dialkylaminoalkyl-n-(2{62 ,19-epoxy-5{60 -androstan-17{62 -yl)amines/formamides and 3{60 -halo derivatives thereof
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
GB8501035D0 (en) * 1985-01-16 1985-02-20 Senior J Prostaglandins
US4882322A (en) * 1988-10-27 1989-11-21 Merrell Dow Pharmaceuticals Inc. 3β,17β-hydroxy-substituted steroids and related steroidal compounds

Also Published As

Publication number Publication date
HU913739D0 (en) 1992-02-28
IL100196A0 (en) 1992-08-18
KR100190776B1 (ko) 1999-06-01
NO180304B (no) 1996-12-16
NZ240738A (en) 1993-11-25
HU210830B (en) 1995-08-28
AU635444B2 (en) 1993-03-18
IL100196A (en) 1996-03-31
US5166201A (en) 1992-11-24
KR920009842A (ko) 1992-06-25
JP3143876B2 (ja) 2001-03-07
CN1061974A (zh) 1992-06-17
NO914710D0 (no) 1991-11-29
CN1033975C (zh) 1997-02-05
CA2056638C (en) 2002-03-05
NO914710L (no) 1992-06-01
FI102073B (fi) 1998-10-15
IE914168A1 (en) 1992-06-03
ATE142639T1 (de) 1996-09-15
PT99661A (pt) 1992-10-30
FI915623A0 (fi) 1991-11-28
HUT59937A (en) 1992-07-28
GR3021981T3 (en) 1997-03-31
FI915623A (fi) 1992-05-31
EP0488383A1 (en) 1992-06-03
ES2094183T3 (es) 1997-01-16
CA2056638A1 (en) 1992-05-31
EP0488383B1 (en) 1996-09-11
ZA919296B (en) 1992-08-26
DK0488383T3 (da) 1996-09-30
DE69122048D1 (de) 1996-10-17
FI102073B1 (fi) 1998-10-15
DE69122048T2 (de) 1997-02-20
AU8812891A (en) 1992-06-04
JPH04290898A (ja) 1992-10-15
NO180304C (no) 1997-04-02

Similar Documents

Publication Publication Date Title
DE3871965T2 (de) Steroid-5-alpha-reduktase-inhibitoren.
US4055641A (en) Method of treating benign prostatic hypertrophy
EP0648778A2 (de) Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
KR100577129B1 (ko) 안드로겐 스테로이드 화합물 및 그의 제조 및 이용 방법
RU2130944C1 (ru) ПРОИЗВОДНЫЕ β БЕНЗАЛЬДОКСИМ-ЭСТРА-4,9-ДИЕНА, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
PT1082338E (pt) 17b-nitro-11b-arilesteróides e seus derivados com propriedades de agonista ou antagonista hormonal
PT99661B (pt) Processo para a preparacao de esteroides 2beta,19-etilenicos ligados em ponte
FI92706C (fi) Menetelmä 19-hydroksylaasi-inhibiittoreina käyttökelpoisten 19-substituoitujen progesteronijohdannaisten valmistamiseksi
JP2750621B2 (ja) ３β，１７β―ヒドロキシ―置換ステロイド及び関連するステロイド化合物類
Wolff et al. Thia steroids. I. 2-Thia-A-nor-5. alpha.-androstan-17. beta.-ol, an active androgen
KR100728088B1 (ko) 안드로젠성 7-치환된 11-할로겐 스테로이드
US20050222104A1 (en) Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids
US5126488A (en) 2β,19-methyleneamino bridged steroids as aromatase inhibitors
BRPI0721050A2 (pt) Derivados de 6-alquoxialquil estradiol e métodos de uso
ES2240454T3 (es) Compuestos esteroideos con un carbociclo concensado en 16,17 que tienen actividad estrogenica selectiva.
KR0140885B1 (ko) 19-플루오로 또는 시아노-21-하이드록시 프로게스테론 유도체
AU2001289889B2 (en) Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids
PT97202A (pt) Processo para a preparacao de inibidores de enzima esteroidais substituidos por halogenoetilo
AU2001289889A1 (en) Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920617

FG3A Patent granted, date of granting

Effective date: 19990208

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20040809